Q: What is Bendeka used for?

Bendeka is used to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma .

Q: How does Bendeka work?

How Bendeka Works Bendeka contains the active ingredient bendamustine, which belongs to a class of medications known as alkylating agents. These drugs are designed to target and kill cells that divide rapidly, a primary characteristic of cancer cells. The medication works through several steps to stop the progression of cancer: DNA Targeting: Once Bendeka enters the bloodstream and reaches the cancer cells, it attaches to the cell's DNA. Cross-linking: The drug forms chemical bonds between the strands of the DNA. This process, called cross-linking, prevents the DNA strands from separating as they normally would during cell division. Stopping Replication: Because the DNA strands cannot separate, the cancer cell is unable to replicate its genetic material or create new cells. Cell Death: When the cell's DNA is damaged beyond repair and it can no longer divide, the cell eventually dies. By interfering with the life cycle of cancer cells, Bendeka helps to reduce the number of abnormal cells in conditions such as chronic lymphocytic leukemia (CLL) and certain types of non-Hodgkin lymphoma (NHL).

Q: What are the active ingredients in Bendeka?

The active ingredient in Bendeka is bendamustine .

Q: What are the side effects of Bendeka?

Common side effects of Bendeka may include: Nausea Fatigue Fever and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Bendeka?

Bendeka belongs to the alkylating agent drug class.

Q: What is the dosage of Bendeka and how do I take it?

How Bendeka is Given Bendeka is administered as an intravenous (IV) infusion into a vein. This procedure is performed by a healthcare professional in a medical facility, such as a hospital or infusion center. Each infusion typically lasts about 10 minutes. Dosing Schedule The medication is generally given on two consecutive days. This two-day treatment period is followed by a rest period, forming a cycle that usually repeats every 21 or 28 days. A healthcare provider will determine the total number of cycles based on the specific condition being treated and how the body responds to the therapy. Missed Doses Because this medication is administered on a strict schedule by a healthcare provider, it is important to keep all scheduled appointments. If an appointment is missed, contact your doctor or clinic immediately to reschedule the treatment.

Q: Is Bendeka safe during pregnancy and breastfeeding?

Pregnancy Risks Bendeka can cause fetal harm when administered to a pregnant woman. Research indicates that the medication may lead to birth defects or the death of a fetus. Patients should inform their healthcare provider immediately if they become pregnant or suspect they are pregnant during treatment. Contraception and Testing Healthcare providers typically perform a pregnancy test before starting Bendeka in individuals who can become pregnant. To prevent pregnancy during and after treatment, the following guidelines are generally recommended: Females: Use effective contraception during treatment and for at least 6 months after the final dose. Males: Use effective contraception (such as condoms) during treatment and for at least 3 months after the final dose if the partner is of reproductive potential. Breastfeeding It is not known whether bendamustine passes into human milk or how it affects milk production. However, because of the risk of serious side effects in a nursing child, breastfeeding is not recommended during treatment and for at least 1 week after the last dose of Bendeka. Fertility Bendeka may impair male fertility, which could affect the ability to father a child. Individuals concerned about future fertility should discuss options for fertility preservation with their medical team before beginning therapy.

Q: What forms and strengths does Bendeka come in?

Available Forms Bendeka is supplied in the following form: Intravenous Injection: A ready-to-use, clear, colorless to yellow solution provided in multi-dose vials. This medication is intended for administration into a vein by a healthcare provider in a clinical setting. Unlike some other formulations of the same active ingredient, this version does not require reconstitution before use.

Q: What is the FDA approval status of Bendeka?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Bendeka (bendamustine hydrochloride) in December 2015. It is a rapid-infusion, low-volume formulation of bendamustine. The medication is approved for the following uses: Chronic lymphocytic leukemia (CLL): Used as a treatment for patients with CLL, though its efficacy compared to first-line therapies other than chlorambucil has not been fully established. Indolent B-cell non-Hodgkin lymphoma (NHL): Used for patients whose disease has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Safety Communications and Monitoring The FDA monitors the safety of Bendeka through the FDA Adverse Event Reporting System (FAERS). In 2016, the FDA identified a potential signal of serious risk regarding severe skin reactions associated with bendamustine products. These reactions include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Following this identification, the FDA required updates to the drug labeling to include warnings about these serious skin conditions. There is currently no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication.

Question 1

What is Bendeka?

Accepted Answer

Bendeka is a chemotherapy medication that belongs to a group of drugs known as alkylating agents. It works by binding to the DNA of cells, which prevents them from dividing and growing.

This action helps to slow or stop the progression of disease by targeting cells that are rapidly multiplying. It is designed to interfere with the growth and spread of specific cells in the body.

Question 2

What is Bendeka used for?

Accepted Answer

Bendeka is used to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma.

Question 3

How does Bendeka work?

Accepted Answer

How Bendeka Works

Bendeka contains the active ingredient bendamustine, which belongs to a class of medications known as alkylating agents. These drugs are designed to target and kill cells that divide rapidly, a primary characteristic of cancer cells.

The medication works through several steps to stop the progression of cancer:

DNA Targeting: Once Bendeka enters the bloodstream and reaches the cancer cells, it attaches to the cell's DNA.
Cross-linking: The drug forms chemical bonds between the strands of the DNA. This process, called cross-linking, prevents the DNA strands from separating as they normally would during cell division.
Stopping Replication: Because the DNA strands cannot separate, the cancer cell is unable to replicate its genetic material or create new cells.
Cell Death: When the cell's DNA is damaged beyond repair and it can no longer divide, the cell eventually dies.

By interfering with the life cycle of cancer cells, Bendeka helps to reduce the number of abnormal cells in conditions such as chronic lymphocytic leukemia (CLL) and certain types of non-Hodgkin lymphoma (NHL).

Question 4

What are the active ingredients in Bendeka?

Accepted Answer

The active ingredient in Bendeka is bendamustine.

Question 5

What are the side effects of Bendeka?

Accepted Answer

Common side effects of Bendeka may include:

Nausea
Fatigue
Fever
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Bendeka?

Accepted Answer

Bendeka belongs to the alkylating agent drug class.

Question 7

What is the dosage of Bendeka and how do I take it?

Accepted Answer

How Bendeka is Given

Bendeka is administered as an intravenous (IV) infusion into a vein. This procedure is performed by a healthcare professional in a medical facility, such as a hospital or infusion center. Each infusion typically lasts about 10 minutes.

Dosing Schedule

The medication is generally given on two consecutive days. This two-day treatment period is followed by a rest period, forming a cycle that usually repeats every 21 or 28 days. A healthcare provider will determine the total number of cycles based on the specific condition being treated and how the body responds to the therapy.

Missed Doses

Because this medication is administered on a strict schedule by a healthcare provider, it is important to keep all scheduled appointments. If an appointment is missed, contact your doctor or clinic immediately to reschedule the treatment.

Question 8

Is Bendeka safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy Risks

Bendeka can cause fetal harm when administered to a pregnant woman. Research indicates that the medication may lead to birth defects or the death of a fetus. Patients should inform their healthcare provider immediately if they become pregnant or suspect they are pregnant during treatment.

Contraception and Testing

Healthcare providers typically perform a pregnancy test before starting Bendeka in individuals who can become pregnant. To prevent pregnancy during and after treatment, the following guidelines are generally recommended:

Females: Use effective contraception during treatment and for at least 6 months after the final dose.
Males: Use effective contraception (such as condoms) during treatment and for at least 3 months after the final dose if the partner is of reproductive potential.

Breastfeeding

It is not known whether bendamustine passes into human milk or how it affects milk production. However, because of the risk of serious side effects in a nursing child, breastfeeding is not recommended during treatment and for at least 1 week after the last dose of Bendeka.

Fertility

Bendeka may impair male fertility, which could affect the ability to father a child. Individuals concerned about future fertility should discuss options for fertility preservation with their medical team before beginning therapy.

Question 9

What forms and strengths does Bendeka come in?

Accepted Answer

Available Forms

Bendeka is supplied in the following form:

Intravenous Injection: A ready-to-use, clear, colorless to yellow solution provided in multi-dose vials.

This medication is intended for administration into a vein by a healthcare provider in a clinical setting. Unlike some other formulations of the same active ingredient, this version does not require reconstitution before use.

Question 10

What is the FDA approval status of Bendeka?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Bendeka (bendamustine hydrochloride) in December 2015. It is a rapid-infusion, low-volume formulation of bendamustine. The medication is approved for the following uses:

Chronic lymphocytic leukemia (CLL): Used as a treatment for patients with CLL, though its efficacy compared to first-line therapies other than chlorambucil has not been fully established.
Indolent B-cell non-Hodgkin lymphoma (NHL): Used for patients whose disease has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

Safety Communications and Monitoring

The FDA monitors the safety of Bendeka through the FDA Adverse Event Reporting System (FAERS). In 2016, the FDA identified a potential signal of serious risk regarding severe skin reactions associated with bendamustine products. These reactions include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).

Following this identification, the FDA required updates to the drug labeling to include warnings about these serious skin conditions. There is currently no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication.

Question 11

What should I know about Bendeka and cost?

Accepted Answer

Administration and Facility Fees

Bendeka is administered as an intravenous infusion by healthcare professionals in a clinical setting, such as a hospital or infusion center. Because it is not a medication you pick up at a retail pharmacy, the total cost often includes the price of the drug itself along with fees for the medical staff, equipment, and the facility where the treatment is provided.

Insurance and Medicare Coverage

Most private insurance plans and Medicare Part B typically cover Bendeka when it is used for FDA-approved indications. Your specific out-of-pocket expenses, such as deductibles, copayments, or coinsurance, will vary based on your individual health plan's benefits and whether the treatment facility is in-network.

Financial Assistance Programs

The manufacturer of Bendeka may offer financial assistance programs, such as co-pay savings cards for eligible patients with commercial insurance. For those who are uninsured or underinsured, patient assistance programs may be available to help cover the cost of the medication. Some independent charitable foundations also provide grants to assist with treatment costs for specific types of cancer.

Generic Alternatives

Generic versions of bendamustine (the active ingredient in Bendeka) are available. Generic medications are generally less expensive than brand-name drugs. You should consult with your healthcare provider or insurance company to determine if a generic version is an appropriate and covered option for your treatment plan.

Bendeka

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Bendeka

Hospitals.net Disclosure